Live Breaking News & Updates on San Biotechnology Value Fund

Stay updated with breaking news from San biotechnology value fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air – Indianapolis Business Journal

Results of a clinical trial for Point Biopharma's lead compound fell short of analysts' expectations, and that development is likely to pressure its investors to decide whether to agree to sell the company to Eli Lilly and Co. for $1.4 billion. ....

William Blair , Eli Lilly , San Biotechnology Value Fund , Point Biopharma , Indianapolis Based Point Biopharma , Biopharma Dive , Fierce Biotech , San Francisco Based Biotechnology Value Fund ,

Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital

In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs Samsara BioCapital. ....

Stanford University , United States , Benjamina Smith , Srini Akkaraju , Matthew Caufield , Principia Biopharma , Catherined Wood , Michael Dybbs , Patrick Trucchio , Srinivas Akkaraju , Takeda Pharmaceutical Company Limited , Recursion Pharmaceuticals Inc , San Biotechnology Value Fund , Chromaderm Inc , Forma Therapeutics Holdings Inc , Principal At Boston Consulting Group , Baron Discovery Fund , Centessa Pharmaceuticals Limited , Genentech Inc , University Of Harvard , Number Of Hedge Fund Holders , Dimension Therapeutics Inc , Ohio State Innovation Foundation , Rain Therapeutics Inc , Sutro Biopharma Inc , Versartis Inc ,